Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus

Li, JH; Wei, Q; McCowen, KC; Xiong, W; Liu, J; Jiang, WLJ; Thomas, RL; Hepokoski, M; He, M; Shyy, JYJ; Malhotra, A; Xiong, N; Li, WX

Li, WX (通讯作者)，Univ Calif San Diego, Dept Med, 9500 Gilman Dr,MC 0716, La Jolla, CA 92093 USA.;Xiong, N (通讯作者)，Wuhan Red Cross Hosp, Dept Endocrinol, 392 Hongkong Rd, Wuhan 430015, Hubei, Peoples R China.

ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (1):

Abstract

Aims Type 2 diabetes mellitus (T2DM) is a strong risk factor for complications of coronavirus disease 2019 (COVID-19). The effect of T2DM medications ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索